Last reviewed · How we verify

NCT03500926: hype

Comparison of a Short Uncemented Femoral Stem to a Similar Standard Uncemented Femoral Stem

Status unknown NA Last updated 18 April 2018
What this trial tests

NA trial testing total hip replacement - standard femoral stem in Osteoarthritis, Hip in 160 participants. Status unknown.

Timeline
9 March 2018
Primary endpoint
9 March 2022
9 March 2025

Quick facts

Lead sponsorAssociation pour le Développement et l'Enseignement de la Chirurgie Réparatrice et Orthopédique
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment160
Start date9 March 2018
Primary completion9 March 2022
Estimated completion9 March 2025
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

Association pour le Développement et l'Enseignement de la Chirurgie Réparatrice et Orthopédique

Who can join

18 and older, any sex, with Osteoarthritis, Hip. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This randomized controlled trial will compare patients receiving a standard uncemented femoral stem with patients receiving an identically designed short uncemented femoral stem.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Radiological stability of a quadrangular uncemented femoral component compared with its shortened version in primary total hip arthroplasty : a prospective randomized controlled trial
    Kruse F, Addi A, Anract P, Biau D. · · 2026

Verify or expand the search:

Other recruiting trials for Osteoarthritis, Hip

Currently open trials in the same condition.

Other Association pour le Développement et l'Enseignement de la Chirurgie Réparatrice et Orthopédique trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03500926.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing